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Abstract 
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The effect of centrally acting opioid analgesic Tramadol on vasopressin induced analgesia 
was evaluated in Swiss albino mice. Analgesia was evaluated in the mice using tail clip and 
writhing test techniques. Animals were divided into control and test groups (n=6). 
Arginine vasopressin (12 µg/kg i.p) and its synthetic analogue, Terlipressin (300 µg /kg i.v) 
injected in the mice produced analgesia by increasing the latency period by 131.6% and 
53.5% respectively and reduced the acetic acid writhing by 45.85 % and 13.51 % 
respectively. Pretreatment with Tramadol (10 mg/kg i.p) potentiated the analgesic action of 
vasopressin and terlipressin  and increased the latency period and reduced the acetic acid 
induced writhings respectively. This study suggests that Tramadol can be combined with 
vasopressin for enhanced analgesic effect. 
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Introduction 
Analgesics are agents that relieve pain by elevating the 
pain threshold with out affecting conciousness (or) alter other 
sensory modalities. There are several methods adapted to 
study pain mechanisms. Some simple techniques include the 
tail clip, tail flick and writhing technique. Pain stimulation 
enhances paraventricular nucleus (PVN) mediated synthesis 
and secretion of arginine vasopressin (AVP). Yang et al  [1] 
showed that PVN and peri-aqueductal gray matter (PAG) play 
a significant role in pain modulation. 
On the other hand, pituitary peptide hormone vasopressin 
has been implicated in the analgesic mechanisms and 
mediates analgesic effect in the mouse [2,3]. Vasopressin is 
released in circulation during stress [4]. It has been suggested 
that endogenous opioids may modulate the vasopressin 
release in man [5] and rodents [6]. Tramadol, a synthetic 
analogue of codeine is a centrally acting analgesic with 
additional non-opioidergic mechanisms. 
This study was conducted to ascertain the effect of 
Tramadol pretreatment on the analgesic activity of vasopressin 
and its synthetic analogue Terlipressin in Swiss albino mice. 
Materials and Methods 
Animal maintenance: Swiss albino mice weighing between 
25-30 g were used for this study. Animals were housed in 
groups of 6-8 animals in propylene plastic cages under 
hygienic conditions, lined with paddy-husk bedding. All 
experiments were conducted during light phase between 8.00 
and 13.00 hrs. All procedures were conducted according to the 
guidelines of the International association for the study of pain 
[7]. 
Drugs and chemicals: Tramadol HCl (Sarabhai Chemicals, 
Baroda, India), Arginine vasopressin (Samarth 
Pharmaceuticals Co., Ltd, India), Normal Saline (E.Merck Ltd, 
India), Terlipressin (Ferring, Denmark), Acetic acid (Qualigens, 
India). 
Determination of Analgesic activity  
Haffner’s Tail Clip Method: This technique first described by 
Haffner in 1954 [8] is a simple technique. Here a steel tail clip 
is applied to the root of the tail of mice to induce pain. Mice  
that responded to the noxious stimuli by turning or biting the 
clip with in 15 seconds are used for the test. 
Writhing Test: The writhing (Abdominal constrictions) test is 
used to measure the changes in pain threshold to a chemical 
stimulus e.g  the injection of acetic acid (0.6%; 0.25ml i.p). 
Analgesia is assessed in mice by noting the abdominal 
constrictions and a decrease in these constrictions is indicative 
of analgesic action. 
Statistical analysis: The results are expressed as mean ± SE 
from n=6 observations. The statistical significance (P<0.05) 
was ascertained by ANOVA and Mann-Whitney U Test.  
Results 
The results of our study are shown in Table 1. AVP and 
Tramadol showed significant analgesic activity i.e 131.6 % and 
73.4 % change in latency period 45.85 % and 65.93% reduction 
in writhings as per our observations on tail clip and abdominal 
writhing. However, Terlipressin showed less analgesic activity 
comparatively 53.5 % and 13.51% respectively. Tramadol 
pretreatment potentiated the analgesic effect of AVP and 
Terlipressin as per our observations of the tail clip and writhing 
tests.
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Table 1: Effect of treatment with AVP (12µg/kg i.p) and Terlipressin (300µg/kg i.v) alone and in combination with Tramadol (10 mg/kg i.p) on the 
analgesic activity in mice. Numbers given in the parentheses below the percentage values describe comparisons of groups for statistical significance 
No. 
(n=6) 
Pre-
treatment 
Treat-ment Tail clip 
test 
(secs) 
% 
change 
‘P’value Writhing 
 Test 
(counts) 
% 
change 
‘P’Value 
1 Saline  Saline  10.5 ± 
9.85 
- - 33.67± 3.09 -  
2 Saline  AVP 24.3± 1.9 131.6 <0.01 
(1:2) 
18.23± 2.45 45.85 
(1:2) 
<0.05 
3 Saline Terli-pressin 16.11 ± 
1.1 
53.5 <0.05 
(1:3) 
29.12 ± 3.41 13.51 
(1:3) 
>0.05 
4 Saline Tramadol 18.2 ± 
1.53 
73.4 <0.05 
 (1:4) 
11.47± 2.91 65.93 
(1:4) 
<0.01 
5 Tramadol AVP 25.56± 
1.61 
143.5 >0.05 
 (2:5) 
11.08 ± 1.71 67.09 
(2:5) 
<0.05 
6 Tramadol Terli-pressin 20.59± 
1.23 
96.15 <0.05 
(3:6) 
21.34 ± 3.79 36.62 
(3:6) 
<0.05 
 
Discussion 
The results of our study clearly show that the analgesic 
action of vasopressin analogues in the mice as determined by 
tail clip and writhing method. The results of our study suggest 
that AVP is much more potent then Terlipressin as an 
analgesic agent as shown in Table 1. This difference may be 
due to the synthetic nature of Terlipressin. It seems that it is 
less potent because it may have different pharmacokinetic 
profile. AVP acts through its G protein coupled receptors 
bound to the adenylate cyclase and phospholipase enzymes 
[9]. Several studies have shown the analgesic activity of AVP 
[10,1,3]. Yang et al have reported that many AVP containing 
fibers in the PAG come from PVN neurons, in which high 
density of endogenous opiate peptide neurons are located. Our 
results support earlier studies conducted by Amit and Galina 
[11] who reported that anti-AVP serum was able to attenuate 
the analgesic effects of AVP as tested by tail clip method. 
We used tramadol, a drug which exhibits a modest affinity 
for µ-opioid and weak affinity for δ and κ opioid receptors [12]. 
Tramadol also inhibits the re-uptake of noradrenaline and 
serotonin [13]. Tramadol is normally used for medium intensity 
short lasting pain. In this study, Tramadol was able to 
potentiate the effects of AVP and Terlipressin although not 
very significantly. A similar study done with Tramadol and a 
different analogue of vasopressin when given in combination 
showed promise in patients with renal colic [14].  Thus, this 
study is a novel study which points to the importance of co-
administration of Tramadol and vasopressin analogues for 
possible therapeutic purpose. 
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